Category: Medicine

The US radiopharmaceuticals giant Lantheus is snapping up the Contract Development and Manufacturing (CDMO) Evergreen Theragnostics as it expands its…

Munich-based biotechnology company Ethris has announced encouraging topline data from a phase 1 clinical trial evaluating its lead messenger RNA…

Novo Nordisk has reported weight loss effects of up to 22% in patients who received a weekly subcutaneous dose of…

The round was led by the US venture capital (VC) firm General Catalyst Partners with participation from compatriot VC Greylock…

Head of solution value at One2Treat, Émilie Barré shares her journey to date with Outsourcing-Pharma. Could you give us an…

Compared to the previous years, 2024 has been a relatively slow year for mergers and acquisitions in the pharmaceutical space.…

Arctic Therapeutics announced this week that it has raised €26.5 million, a sum bankrolled by investors including the European Innovation…

Results from the STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight loss effects…

Australian contract development and manufacturing organizations (CDMOs), BioCina and NovaCina, have merged in a move to pool their biologic and…

We ran a Q&A With Michael Young, co-founder of Lindus Health on the challenges of 2024 and the company’s goals…

We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape of patient…

Stakeholders across the clinical trials and digital health industry will be gathering next month in Orlando at the Summit for…

Ashley Davidson, vice president of sponsor and tech strategy at Advarra, discusses her outlook for this year’s edition of the…

The evolution of clinical trials is being driven by an increased focus on patient perspectives and innovative statistical methodologies. Regulatory…

As pharmaceutical pipelines and R&D investments expand worldwide, the global market for clinical trials is projected to grow by almost…

Johnson & Johnson has entered an acquisition agreement with drug developer Intra-Cellular Therapies priced at $14.6bn, positioning the deal as…

As the Cambridge Healthtech Institute (CHI) celebrates its 16th annual Clinical Ops Executives (SCOPE) Summit in Orlando, Florida, USA, next…

The company’s launch is backed by an oversubscribed Series A round of $411m co-led by Forbion and General Atlantic. RA…

As India’s contract manufacturing and development organization (CDMO) is set to double in the next decade, Anthem Biosciences is planning…

Denali Therapeutics has announced topline results from the phase 2/3 Healey ALS Platform Trial, which evaluated the effects of its…

Orbis was founded in 2021 by the Seeds Investment team of Novo Holdings, the assets and wealth manager of the…

Palatin Technologies has announced topline results for the phase 2b Breakout study, which evaluated the effects of bremelanotide in patients…

According to the terms of the deal, Gilead will select a set of drug targets and Terray will discover and…

Founded by a team of scientists and healthcare specialists in 2021, Nintx harnesses compounds from Brazil’s world-famous plant ecosystems to…

AbbVie and Nimble Therapeutics have announced an acquisition deal in which AbbVie will gain ownership of the company’s pipeline of…

The company creator General Inception (GI) has acquired Enable Medicine to pool its know-how regarding drug development and the biotech…

Noema Pharma has announced an extension of its series B financing round, bringing the total raised up to $147 million…

Shortly after acquiring a manufacturing site in Wisconsin, Eli Lilly intends to expand it to boost its production of injectable…

Pharma company, AbbVie, reports that its D1/D5 partial agonist, tavapadon, has met the primary and secondary endpoints in a pivotal…

PTC Therapeutics announced this week that it has made a deal with Novartis for global rights to its oral Huntington’s…

Investment in radiopharmaceuticals is ramping up as big pharma shows a growing appetite for this promising drug modality. Radiopharmaceuticals see…

The pharma arm of Mitsubishi Chemical Group has launched a collaboration with US-based Dewpoint Therapeutics to co-develop a preclinical-stage treatment…

The pharmaceutical business unit of the German giant Körber has snapped up the compatriot label and leaflet supplier Wilhelm Bähren…

Swiss oncology specialist Novocure has announced positive topline results from the PANOVA-3 phase 3 clinical trial, which evaluated the use…

While these sites are important for clinical research, they make patient recruitment challenging. Many participants are forced to travel to…

However, nonspecific binding (NSB) can hinder PK assays, impacting their accuracy and reliability. Fortunately, there are strategies and best practices…

Eli Lilly has released detailed results from the SURMOUNT-1 phase 3 trial, where over 1,000 obese or overweight prediabetic participants…

NVentures also participated in the company’s $200 million Series B last August.  This strengthened collaboration is aimed at advancing Genesis’…

C Ray Therapeutics has announced the completion of a series A+ financing round, which has exceeded the $100 million mark.…

With around $2 billion of the investment dedicated to creating more than a thousand U.S. jobs, AstraZeneca is looking to…

The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational small molecule…

Spray drying involves converting pharmaceutical liquid solutions into tiny droplets that are rapidly dried with hot gases such as nitrogen.…

AstraZeneca has reported positive results from the CAPItello-281 phase 3 trial, which evaluated Truqap (capivasertib) in combination with Johnson &…

What’s new at leading trade publication Outsourcing Pharma

Founded in Munich in 2020, Adragos’ global manufacturing sites were acquired from other players including Haupt Pharma Livron, LAW Pharma,…

According to a recent report by Business Research Insights, the total size of the global decentralized clinical trials market was…

eCOA and ePRO (electronic patient-reported outcome) technology are transforming clinical trials, offering streamlined processes for patients, sites, and sponsors. In…

Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its investigational small molecule drug, Muvalaplin, against cardiovascular events.…

Now the Global market development manager at Phenomenex, she thrives on connecting insights with solutions, all while channeling the wisdom…

Now leading the Biopharma product management team at Phenomenex, she brings a problem-solving mindset honed by a love of forensic…

The global contract development and manufacturing organization (CDMO), Samsung Biologics, announced this week that it has entered into a collaboration…

The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment, HYMPAVZI (marstacimab),…

Sameer Sabir, CEO and co-founder of Brixton Biosciences, aims to revolutionize pain management. With Neural Ice, the company’s groundbreaking drug-free…

The phase 3 ICONIC-LEAD study showed that icotrokinra, a peptide drug that blocks the interleukin (IL)-23 receptor, was able to…

The phase 3 ICONIC-LEAD study showed​ that icotrokinra, a peptide drug that blocks the interleukin (IL)-23 receptor, was able to…

The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment, HYMPAVZI (marstacimab),…

C Ray Therapeutics has announced the completion of a series A+ financing round, which has exceeded the $100 million mark.…

Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its investigational small molecule drug, Muvalaplin, against cardiovascular events.…

Under the terms of the merger agreement, Avid Bioservices will be acquired by funds managed by GHO and Ampersand in…

At the helm of Coronado’s scientific strategy, Professor Visser-Rogers envisions a data-driven future powered by innovative methodologies and emerging technologies.…

Gifthealth has announced a strategic partnership with United Digestive, a leading practice management organization for gastroenterology. This is to enhance…

Conducted with 136 US-based participants across multiple health conditions, the survey found that 63% said they would be more likely…

Medable, a provider of clinical development technology, has announced a collaboration with Google Cloud to bring its decentralized clinical trial…

However, nonspecific binding (NSB) can hinder PK assays, impacting their accuracy and reliability. Fortunately, there are strategies and best practices…

This forms part of an expanded partnership to enhance Genesis’ AI-powered drug discovery platform, GEMS (Genesis Exploration of Molecular Space).…

Eli Lilly has released detailed results from the SURMOUNT-1 phase 3 trial, where over 1,000 obese or overweight prediabetic participants…

With around $2 billion of the investment dedicated to creating more than a thousand U.S. jobs, AstraZeneca is looking to…

According to a recent report​ by Business Research Insights, the total size of the global decentralized clinical trials market was…

While these sites are important for clinical research, they make patient recruitment challenging. Many participants are forced to travel to…

According to the topline results, a total of 54% of patients given the treatment saw their tumors shrink compared to…

CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced technologies for patient safety,…

Epilepsy is one of the most common neurological conditions​ in the world, with around 50 million people with the condition.…

By offering comprehensive, integrated solutions, Abzena aims to streamline drug development processes and minimize risks for customers, helping to accelerate…

Tim Davis, vice president of strategy at Veeva eCOA, had a conversation with Outsourcing Pharma’s senior editor, Liza Laws, and…

Ascendis Pharma has granted Novo Nordisk an exclusive worldwide license to its TransCon technology platform for the development, manufacturing and…

Silmitasertib, also known as CX-4945, was originally developed by Cylene Pharmaceuticals, a San Diego-based biotech that ceased operations in 2013.…

The Palomar Health Foundation recently completed its third annual Middle School Medical Discoveries (Middle School MD) program, engaging local youth…

Starget Pharma, an Israeli startup developing AI-powered precision therapies for difficult-to-treat cancers, has secured a $5.1 million investment from MD…

Novo Nordisk has released data from the SELECT phase 3 trial showing that a 2.4 mg dose of semaglutide reduced…

Novartis’ Scemblix (asciminib) has received accelerated approval by the US FDA as a treatment for adult patients with newly diagnosed…

A new case study from AllazoHealth demonstrates that a top 10 rare disease pharmaceutical company experienced a 10.4% increase in…

This integration aims to create a unified lab management experience, offering scientists enhanced data traceability, security, and streamlined workflows across…

In an exclusive interview, Vicky shares insights on her career, the challenges she faced, and her passion for inspiring the…

From reducing operational costs to enhancing patient outcomes, Stevanato Group is at the forefront of digital transformation in pharma. Digital…

Since the FDA approval of Novo Nordisk’s Wegovy as a treatment for chronic weight management in 2021, followed by the…

Epilepsy is one of the most common neurological conditions​ in the world, with around 50 million people with the condition.…

With a background spanning biotech and executive roles at Medtronic, Anu brings a unique blend of resilience, collaboration, and strategic…

This alliance marks a shift in biopharma R&D, with the launch of the Biophysics Institute for Biomedical Research (IBRB), offering…

Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) will be increasing its production at its headquarters in Laupheim…

GSK is one of the world’s biggest pharmaceutical companies with products ranging from the shingles vaccine Shingrix and the HIV…

Modifi Biosciences, a spin out of Yale University founded in 2021, has been snapped up by Merck for $30 million…

Radiopharmaceuticals consist of radioactive isotopes that are chemically attached to small molecules, peptides or protein drugs such as antibodies. These…

The EU first gave Translarna a conditional marketing authorization in 2014 for the treatment of DMD, a progressive condition that…

Modifi Biosciences, a spin out of Yale University founded in 2021, has been snapped up by Merck for $30 million…

Radiopharmaceuticals consist of radioactive isotopes that are chemically attached to small molecules, peptides or protein drugs such as antibodies. These…

A new Alzheimer’s treatment, donanemab, has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), but a draft…

Seaport has developed a platform called Glyph designed to enhance efficacy and reduce the side effects of potential drug candidates.…

The EU first gave Translarna a conditional marketing authorization in 2014 for the treatment of DMD, a progressive condition that…

Find out all about her intriguing journey to where she is now in her role as marketing manager within small…

Lundbeck and Longboard Pharmaceuticals have announced an agreement for the Danish pharmaceutical company to acquire all outstanding shares of Longboard,…

Techbio is a field where the computational expertise of the tech sector and the biological know-how of the biotech sector…

With a career spanning monoclonal antibodies and now cell therapies, she expertly navigates complex regulatory landscapes to bring life-changing treatments…

Outsourcing Pharma caught up with experts from the global CDMO, CordenPharma, to learn how they maintain their competitive edge. Brittany…

The K2 trial tested oditrasertib’s safety and ability to reduce the blood levels of neurofilament light chain, a biomarker of…

With a background in pharmacy and specialized pediatric care, she now bridges bioinformatics with practical, user-friendly tools, empowering clinicians to…

Now a global market development manager, she plays a pivotal role in shaping solutions for food safety and environmental protection.…

Eric Prugh is the chief product officer at Authenticx, a US-based company that recently launched an AI solution to detect…

The significant advantages it offers include: Large reduction in COGS: By 2025, EnzeneX 2.0 expects to produce 40 kg/1000 L…

These siliconized vials are designed to protect sensitive, aggressive, and viscous drug products by reducing interactions with the glass and…

He will also be explaining how the company is expanding its Translational Pharmaceutics platform into new therapeutic areas like mRNA,…

Innovent Biologics and Jiangsu Aosaikang Pharmaceutical (Ask Pharm) have announced a strategic collaboration regarding limertinib, a third-generation epidermal growth factor…

Danish techbio company Evaxion Biotech has published results showing the outcome of three clinical trials comparing the prediction scores of…

Dyslipidemia, a condition involving unhealthy levels of cholesterols and other fats in the blood, is a major risk factor in…

Antag Therapeutics has announced that the FDA has accepted the investigational new drug (IND) application for its lead drug candidate,…

One area it is thriving is pharmaceuticals as it is being used to bring drugs to market faster than ever…

But what does the Act mean for the biotech and pharma industry and how can companies best prepare for any…

One of Recipharm’s main aims is the expansion of its oral solid dosage and sterile fill & finish services in…

One of Recipharm’s main aims is the expansion of its oral solid dosage and sterile fill & finish services in…

The event provides a great platform for the company to present its newest addition—a 20,000 sq ft facility in Stirling,…

We also delve into the latest trends, the rise of AI and the increasing focus on sustainability. How has the…

The company explains attendees will gain insight into how Ardena’s innovations can streamline drug development for advanced therapies, particularly in…

The company says this new platform is specifically designed to administer large-volume injectable therapies, including highly viscous biological drugs, making…

The success of these trials hinges on finding and enrolling the right patients in a timely manner. Eben Scanlon, chief…

The expansion involves setting up a new facility, which is planned to begin operations in late 2026. The facility, which…

Find out all about her intriguing journey to where she is now in her role as marketing manager within small…

UK-based company LoQus23 Therapeutics has announced the closing of a £35 million series A round to advance its pipeline of…

Her journey in life sciences began with a deep childhood curiosity about the natural world, leading to a career in…

From asking endless questions about the causes of illness as a young girl to pioneering therapeutic innovations as an adult,…

The findings come from the HIV Prevention Trials Network (HPTN) 084 open label extension (OLE) study, which evaluated cis-gender women…

Her leadership encompasses visionary support, development, and advocacy for FIP’s 144 member organizations, representing four million members globally. Dr. Duggan’s…

This partnership aims to revolutionize the understanding and treatment of various tremor conditions, using the combined expertise of both organizations…

She has a PharmD-PhD in Medical Physics and is a seasoned professional with a deep understanding of healthcare, law, and…

The expansion will cover existing facilities as well as brand new constructions. CordenPharma aims for all its facilities to meet…

Genentech, a Roche Group member, announced​ this week that its investigational oral, glucagon-like peptide-1 (GLP-1) receptor agonist CT-996 showed good…

The manufacturing and regulatory process of biopharmaceuticals is highly complex and costly to implement, which can be challenging for big…

The companies will jointly control Cosette, with a focus on accelerating innovation and growth. Since Avista’s initial investment in Cosette…

This marks the third FDA approval for Voquenza, which is also approved for treating all severities of Erosive Esophagitis (EE),…

With an impressive career spanning 35 years in the healthcare industry, Fathallah shares his vision for the future of DIA…

This significant project is set to create 232 jobs in Pitt County and marks a milestone in Nipro’s expansion into…

This state-of-the-art facility not only doubles IDT’s production capacity but also introduces cutting-edge technologies and energy-efficient measures to enhance gene…

By leveraging diverse data sources and advanced analytics, the company says it empowers the healthcare continuum to make informed clinical…

This accomplishment highlights the company’s creative approach and steady march towards completing 15 harvests within the calendar year. With its…

Investment in psychedelic drugs started booming in 2020. The lockdowns brought by the Covid-19 pandemic highlighted the importance of mental…

In an insightful interview, Tim Martin, vice president, product, at Yseop, discusses the company’s recent advancements, notable collaborations, and the…

This innovation is poised to transform patient access to cancer care by leveraging advanced AI capabilities to provide personalized treatment…

Her insights, captured in the white paper “Closing the Gap in Our Understanding of Sleep Health with Fit-for-Purpose Wearable Digital…

Tyra Biosciences has released positive results from a preclinical proof of concept study testing its lead drug candidate, TYRA-300, in…

Industry leaders give their takes on what else is in store for AI-based tools in the pharma space. AI-powered algorithms…

Bakshi shares the innovative approach of YCT-529, the results of their Phase 1a study, and the anticipated impact on reducing…

 In this interview, she shares insights into her role, personal journey, challenges faced, and advice for aspiring women in science.…

This Q&A with Sheeba Ibidunni, public health expert and the VP of operations ​at Sonara Health explores the socio-economic factors fuelling…

The initiative seeks to understand the crucial role of the omentum, a lesser-known yet vital organ in cancer treatment and…

The IP-protected CBD intermediate brings superior functionality allowing for a higher drug loading compared to currently commercially available products, paving…

With a lot of familial inspiration, an early love of science developed for Pam James, here we find out how…

Ginny brings a wealth of knowledge and experience to the table from her diverse background in nursing, law, and regulatory…

Eli Lilly has entered a strategic partnership with Radionetics Oncology, a biotechnology company focusing on the discovery and development of…

The deal was supported by Keensight Capital, a private equity manager focusing on pan-European investments in the technology and healthcare…

Tyra Biosciences has released positive results from a preclinical proof of concept study testing its lead drug candidate, TYRA-300, in…

Her insights, captured in the white paper “Closing the Gap in Our Understanding of Sleep Health with Fit-for-Purpose Wearable Digital…

The construction project will be financed until 2026 by a €100 million ($108 million) investment by the company. The facilities,…

Results from the PARADIGM clinical trial have revealed that PrimeC, a treatment being developed by NeuroSense Therapeutics, was able to…

This collaboration aims to unite experts from various fields to explore how emerging protein science can address the challenges in…

YonaLink, a pioneering company in digital healthcare, is set to change that. In an in-depth interview with senior editor, Liza…

Also known as precision medicine, this kind of individualized treatment is designed specifically for the patient and has revolutionized cancer…

These efforts are driven by the need for transparency, compliance, and sustainability in response to pressures from stakeholders, including investors,…

This groundbreaking approval is expected to transform the market for patients suffering from moderate to severe exacerbations, particularly those with…

Check out five upcoming AI players attracting investor attention for their potential to speed up drug discovery. Drug discovery is…

YonaLink, a pioneering company in digital healthcare, is set to change that. In an in-depth interview with senior editor, Liza…

In an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s stool test for colorectal cancer…

This expansion, one of the largest in the company’s history, aims to enhance the production of injectable treatments for obesity…

Ginny brings a wealth of knowledge and experience to the table from her diverse background in nursing, law, and regulatory…

With his background in psychiatry, Michael observed the daily struggles of patients in Opioid Treatment Programs and developed Sonara to…

CluePoints is a cloud-based software platform specializing in Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials. The…

IQVIA recognized the intricate challenges associated with participant payments in clinical trials, which often involve cumbersome processes and multiple vendors,…

In an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s stool test for colorectal cancer…

The panel featured Ariel Berger, executive director of integrated solutions and real-world evidence at Aventura; John Van Hoy, executive director…

This guideline, which ensures regulatory compliance with the requirements of ICH GCP E6, came into effect on 9 September 2023.…

Last year, Astellas Pharma established a behavioral science consortium to perform research aimed at better understanding what matters to patients…

This first-of-its-kind phase 2 grant will expedite the commercialization of cannabinoid ingredient production via precision fermentation. The funding aims to…

The expansion will introduce 200,000 sq. ft. of additional space, addressing the growing demand for Grade-A facilities amid a rising…

However, the eCOA/ePRO market has seen minimal innovation since the transition from paper-based forms to digital formats two decades ago,…

Spectrum supports study teams by providing real-time predictions and control over trial timelines and costs, ensuring successful trials in today’s…

The conversation delves into the complexities of signal management in the PV landscape, highlighting recent advancements and the challenges faced…

CluePoints is a cloud-based software platform specializing in Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials. The…

This guideline, which ensures regulatory compliance with the requirements of ICH GCP E6, came into effect on 9 September 2023.…

This expansion of Thermo Fisher’s clinical trial network in Europe will help foster global clinical trial innovation and provide biorepository…

This new medication, approved by the US FDA in October 2023, combines 1,000 mg of acetaminophen and 300 mg of…

This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and its active…

Spectrum supports study teams by providing real-time predictions and control over trial timelines and costs, ensuring successful trials in today’s…

This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and its active…

In a groundbreaking development, Systech, a subsidiary of Markem-Imaje and Dover, has introduced a turnkey manual aggregation and rework solution…

However, the eCOA/ePRO market has seen minimal innovation since the transition from paper-based forms to digital formats two decades ago,…

Promising to redefine the landscape with its latest solutions, the company hopes to take center stage, offering advancements in data…

John Romano, president, and co-founder, shares exclusive insights into how these innovations are set to tackle industry challenges and enhance…

This was to discuss what they describe as the groundbreaking impact of their Sub-population Optimization & Modeling Solution (SOMS). This…

Advarra is set to reveal solutions tailored to address current challenges in the pharmaceutical and healthcare industries. With the results…

This innovative technology allows study teams to predict, optimize, and control trial timelines and costs in real-time, enabling iterative feasibility…

The center, envisioned as a hub for groundbreaking research and development in pharmaceutical sciences, has thus far successfully lived up…

Enter Stardog, an AI and data startup at the forefront of revolutionizing how drugs are brought to market. As pharmaceutical…